US Acute Care Solutions Names Dr. Dominic J. Bagnoli Executive Chairman and James Frary Chief Executive Officer

Cambridge, UK, 16 April 2018 – Abzena plc (AIM: ABZA, ‘Abzena’ or the ‘Group’), a life sciences group providing services and technologies enabling the development and manufacture of biopharmaceutical products, today announces its unaudited pre-close update for the year ended 31 March 2018 (‘FY2018’).Following a stronger second half to the year, the Group expects to report revenue for the full year